Kolkata hospital awaits DGCI nod to begin Phase 2 trial of Russia's Sputnik V COVID-19 vaccine

The RDIF has also partnered with Dr Reddy's Lab to supply 100 million doses of its COVID-19 vaccine in development.

Press Trust of India November 04, 2020 17:15:11 IST
Kolkata hospital awaits DGCI nod to begin Phase 2 trial of Russia's Sputnik V COVID-19 vaccine

Russian's Sputnik V COVID-19 vaccine is also under WHO's pre-approval process. Image: RDIF

If all goes well, Phase-II clinical trials of Russian vaccine Sputnik V will commence at state government-run College of Medicine and Sagore Dutta Hospital by the end of this month, a senior official of the health department said on Tuesday. The necessary surveys – which include visiting the hospital to check its infrastructure and cold storage facilities – have been carried out by a site management organization before starting the process, he stated.

Snehendu Koner, the head of business development at site management organization CliniMed LifeSciences, said a report on survey findings has been sent to the Drug Control General of India (DCGI) for approval.

"We have visited the site, conducted checks on its infrastructure as well as facilities for storing vaccines and immunogenicity samples.

"We have also gone through the hospital's records and found it has experiences of conducting clinical trials. Our findings are quite satisfactory, and we have sent it to the DCGI for approval," Koner told PTI when contacted.

Once the DCGI gives green signal, the hospital's ethics committee will issue a clearance to start the Phase-II clinical trials there, he said.

"We have also identified the principal investigator as well the co-investigator for the process," he said.

The clinical trial of Sputnik V, scheduled to be held throughout the country, will be conducted by pharma company Dr Reddy's Lab, which has joined hands with the Russian Direct Investment Fund (RDIF).

According to a health department official, the RDIF will be supplying 100 million doses of its potential COVID-19 vaccine to Dr Reddy's Lab.

Hundred volunteers will be chosen all over the country, and out of them 75 will be administered the vaccine.

Twenty-five others will be given placebo – a substance or treatment which is designed to have no therapeutic value.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

How COVID-19 vaccines are implemented may matter just as much as their efficacy, says study
India

How COVID-19 vaccines are implemented may matter just as much as their efficacy, says study

The study suggests that the impact of a COVID-19 vaccine — no matter how great its efficacy — reduces dramatically as the severity of the epidemic increases

As race to COVID-19 vaccine heats up, a look at major jabs, development and clinical trials underway
India

As race to COVID-19 vaccine heats up, a look at major jabs, development and clinical trials underway

According to WHO, there are 48 COVID-19 vaccine candidates are undergoing clinical evaluation, of which eleven are at late-stage trials, whereas, 164 candidate vaccines are in preclinical evaluation

COVID-19 vaccine to reach 30 cr by July-Aug, says Harsh Vardhan; healthcare workers, people above 65 yrs priority
India

COVID-19 vaccine to reach 30 cr by July-Aug, says Harsh Vardhan; healthcare workers, people above 65 yrs priority

Stating that everything is being decided by experts with a scientific point of view, the Union health minister expressed confidence that the COVID-19 vaccine will be ready in the next three to four months